ABLi Therapeutics

ABLi Therapeutics is a developing small molecule inhibitors to treat diseases resulting from Abelson Tyrosine Kinase dysfunction (Abl kinases or c-Abl). The Company is engineering its Abl kinase inhibitors to treat Parkinson’s disease, Parkinson’s-related neurodegenerative diseases and other neurolo... Read more